These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 31615525)

  • 1. Implementation of a group-based diabetes prevention program within a healthcare delivery system.
    Azar KMJ; Nasrallah C; Szwerinski NK; Petersen JJ; Halley MC; Greenwood D; Romanelli RJ
    BMC Health Serv Res; 2019 Oct; 19(1):694. PubMed ID: 31615525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and Facilitators to Real-world Implementation of the Diabetes Prevention Program in Large Healthcare Systems: Lifestyle Coach Perspectives.
    Halley MC; Petersen J; Nasrallah C; Szwerinski N; Romanelli R; Azar KMJ
    J Gen Intern Med; 2020 Jun; 35(6):1684-1692. PubMed ID: 32291720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of implementation mapping to develop strategies for integrating the National Diabetes Prevention Program into primary care clinics.
    Perkison WB; Rodriguez SA; Velasco-Huerta F; Mathews PD; Pulicken C; Beg SS; Heredia NI; Fwelo P; White GE; Reininger BM; McWhorter JW; Chenier R; Fernandez ME
    Front Public Health; 2023; 11():933253. PubMed ID: 37181720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A group-based lifestyle intervention for diabetes prevention in low- and middle-income country: implementation evaluation of the Kerala Diabetes Prevention Program.
    Aziz Z; Mathews E; Absetz P; Sathish T; Oldroyd J; Balachandran S; Shetty SS; Thankappan KR; Oldenburg B
    Implement Sci; 2018 Jul; 13(1):97. PubMed ID: 30021592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation findings from a hybrid III implementation-effectiveness trial of the Diabetes Prevention Program (DPP) in the Veterans Health Administration (VHA).
    Damschroder LJ; Reardon CM; AuYoung M; Moin T; Datta SK; Sparks JB; Maciejewski ML; Steinle NI; Weinreb JE; Hughes M; Pinault LF; Xiang XM; Billington C; Richardson CR
    Implement Sci; 2017 Jul; 12(1):94. PubMed ID: 28747191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the University of California Diabetes Prevention Program (UC DPP) Initiative.
    Gholami M; Jackson NJ; Chung UYR; Duru OK; Shedd K; Soetenga S; Loeb T; Elashoff D; Hamilton AB; Mangione CM; Slusser W; Moin T
    BMC Public Health; 2021 Sep; 21(1):1775. PubMed ID: 34592981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the Diabetes Prevention Program in Georgia Cooperative Extension According to RE-AIM and the Consolidated Framework for Implementation Research.
    Wilson HK; Wieler C; Bell DL; Bhattarai AP; Castillo-Hernandez IM; Williams ER; Evans EM; Berg AC
    Prev Sci; 2024 Apr; 25(Suppl 1):34-45. PubMed ID: 36930404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation lessons learned from the University of California's Diabetes Prevention Program Initiative.
    Loeb TB; Ramm K; Gholami M; Shedd K; Soetenga S; Bhagat M; Jackson NJ; Chung UYR; Duru OK; Mangione CM; Hamilton AB; Moin T
    BMC Public Health; 2024 Oct; 24(1):2777. PubMed ID: 39394103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Formative Evaluation of a Diabetes Prevention Program Using the RE-AIM Framework in a Learning Health Care System, Utah, 2013-2015.
    Brunisholz KD; Kim J; Savitz LA; Hashibe M; Gren LH; Hamilton S; Huynh K; Joy EA
    Prev Chronic Dis; 2017 Jul; 14():E58. PubMed ID: 28727546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial.
    Damschroder LJ; Moin T; Datta SK; Reardon CM; Steinle N; Weinreb J; Billington CJ; Maciejewski ML; Yancy WS; Hughes M; Makki F; Richardson CR
    Implement Sci; 2015 May; 10():68. PubMed ID: 25962598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of delivery modes for lifestyle advice in a large scale randomised controlled obesity prevention trial.
    Kozica SL; Lombard CB; Ilic D; Ng S; Harrison CL; Teede HJ
    BMC Public Health; 2015 Jul; 15():699. PubMed ID: 26205958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a large healthy lifestyle program: informing program implementation and scale-up in the prevention of obesity.
    Kozica SL; Lombard CB; Harrison CL; Teede HJ
    Implement Sci; 2016 Nov; 11(1):151. PubMed ID: 27881146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a RE-AIM framework to identify promising practices in National Diabetes Prevention Program implementation.
    Nhim K; Gruss SM; Porterfield DS; Jacobs S; Elkins W; Luman ET; Van Aacken S; Schumacher P; Albright A
    Implement Sci; 2019 Aug; 14(1):81. PubMed ID: 31412894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and outcomes of the New York State YMCA diabetes prevention program: a multisite community-based translation, 2010-2012.
    Bozack A; Millstein S; Garcel JM; Kelly K; Ruberto R; Weiss L
    Prev Chronic Dis; 2014 Jul; 11():E115. PubMed ID: 25010997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program.
    Vojta D; Koehler TB; Longjohn M; Lever JA; Caputo NF
    Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S301-6. PubMed ID: 23498291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery.
    Kramer MK; Kriska AM; Venditti EM; Miller RG; Brooks MM; Burke LE; Siminerio LM; Solano FX; Orchard TJ
    Am J Prev Med; 2009 Dec; 37(6):505-11. PubMed ID: 19944916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilevel perceptions of the virtual delivery of the University of California Diabetes Prevention Program on RE-AIM domains due to COVID-19 mandates.
    Loeb TB; Gholami M; Ramm K; Shedd K; Soetenga S; Jackson NJ; Chung UYR; Duru OK; Mangione CM; Hamilton AB; Moin T
    Front Public Health; 2024; 12():1327429. PubMed ID: 38525342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the Diabetes Prevention Program for Obesity Treatment in Real World Clinical Practice in a Middle-Income Country in Latin America.
    Armenta-Guirado B; Martínez-Contreras T; Candia-Plata MC; Esparza-Romero J; Martínez-Mir R; Haby MM; Valencia ME; Díaz-Zavala RG
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31581478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation.
    Penn L; Rodrigues A; Haste A; Marques MM; Budig K; Sainsbury K; Bell R; Araújo-Soares V; White M; Summerbell C; Goyder E; Brennan A; Adamson AJ; Sniehotta FF
    BMJ Open; 2018 Feb; 8(2):e019467. PubMed ID: 29467134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telehealth Diabetes Prevention Program for Adults With Prediabetes in an Academic Medical Center Setting: Protocol for a Hybrid Type III Trial.
    Gamble A; Khan T; Hughes A; Guo Y; Vasaitis S; Bidwell J; Christman B
    JMIR Res Protoc; 2023 Nov; 12():e50183. PubMed ID: 37955955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.